News

Following voluntary market withdrawal from Covis Pharma, the FDA has decided to withdraw the approval of Makena and its generics for reducing the risk of preterm birth.

A multi-country survey revealed 50% of meningitis vaccination appointments were delayed or canceled amid the COVID-19 pandemic, highlighting the need for “urgent action” to maintain routine vaccination levels among children, according to survey authors.

Patricia Hunt, BS, MS, PhD, discusses how prenatal development is impacted by parental age, along with the significance of researching this association.

New data from a study in Egypt suggests that several key factors contribute to some of the negative impacts of psoriasis on mothers of children with the skin condition.

Data suggest confirmatory trials conducted for drugs granted accelerated approval by the FDA have taken a median 3.5 years to complete since 2012.

With concerns of potential Bacillus cereus contamination, Atovaquone oral suspension, USP 750mg/5mL has been voluntarily recalled by Camber Pharmaceuticals Inc.

In a recent study, states enacting a 20-week abortion ban from 2011 to 2018 had increased rates of neonatal Down Syndrome diagnoses.

These findings suggest the World Health Organization's definition of post-COVID-19 condition (long COVID) may be too broad.

Data pulled from 11 communities in the Autism and Developmental Disabilities (ADDM) Network demonstrate higher autism prevalence for children aged 8 years.

The latest scientific statement from the American Heart Association takes aim at offering clinicians with a summary of contemporary evidence related to the prevalence and increase in long-term risk associated with hypertension in children and adolescents.

Multiple studies have indicated a greater risk of neonatal morbidity and mortality when births occur in out-of-hospital settings.

The North American Society for Pediatric and Adolescent Gynecology’s position statement to eliminate period poverty has acquired a recent endorsement from the American Academy of Pediatrics. 

Children exposed to maternal COVID-19 during pregnancy showed lower birth weight, lower birth BMI, and accelerated postnatal weight gain, compared with those unexposed.

A recent analysis showed that a combination treatment made of phosphate, adapalene, and benzoyl peroxide known as IDP-126 was well-tolerated and effective in pediatric participants with acne.

Children treated after presenting spinal muscular atrophy (SMA) symptoms maintained all previously achieved motor milestones up to 7.5 years post-dosing.

In a recent study, female offspring of mothers with a positive COVID-19 test during pregnancy were at a decreased risk of developing neurodevelopmental disorders compared to male offspring.

Leniolisib is the first and only treatment approved in the United States for APDS, a rare primary immunodeficiency.

Pediatric patients with BRAF V600E low-grade glioma as young as 1 year can now be treated with dabrafenib plus trametinib following its FDA approval.

A recent survey from the C.S. Mott Children’s Hospital National Poll on Children’s Health revealed how addictive parents believe vaping is for children.

All children included in the analysis achieved swallowing, oral nutrition, and airway protection outcomes.

Exposure to a common seasonal coronavirus stimulates a memory T cell response that protects children against COVID-19. However, this immune response peaks at age 6.

Recent data revealed a 110% increase in speech disorder diagnoses for children aged 0 to 12 years in 2022, compared to the pre-pandemic era.

In a recent review, children with vaccination against human papillomavirus (HPV) initialized at a younger age were more likely to receive their full vaccination series.

As little as 39 minutes less sleep per night for 1 week can have an impact on the quality of life of children.

In a recent study, reductions in body mass index along with further beneficial effects were found when using oral butyrate supplementation for treating pediatric obesity.

At the 44th National Association of Pediatric Nurse Practitioners Conference, drug products abused by teenagers were discussed.

At the 44th National Association of Pediatric Nurse Practitioners Conference, methods of treating atopic dermatitis were discussed.

At the 44th National Association of Pediatric Nurse Practitioners Conference, pediatric aggression was discussed, including which patients are at greater risk and which management strategies are most appropriate.

At the 44th National Association of Pediatric Nurse Practitioners Conference, guidelines for prescribing oral contraceptives were discussed.

At the 44th National Association of Pediatric Nurse Practitioners Conference, evidence-based approaches for supporting pregnant adolescents were discussed.